Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Cluster analysis
European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (QLQ-C30)
Health-related quality of life (HRQoL)
Patient reported outcomes
Randomized clinical trials (RCTs)
Journal
European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
01
02
2022
revised:
18
03
2022
accepted:
30
03
2022
pubmed:
16
5
2022
medline:
29
6
2022
entrez:
15
5
2022
Statut:
ppublish
Résumé
The European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) measures 15 health-related quality of life (HRQoL) scales relevant to the disease and treatment of patients with cancer. A study by Martinelli (2011) demonstrated that these scales could be grouped into three main clusters: physical, psychological and gastrointestinal. This study aims to validate Martinelli's findings in an independent dataset and evaluate whether these clusters are consistent across cancer types and patient characteristics. Pre-defined criteria for successful validation were three main clusters should emerge with a minimum R-squared value of 0.51 using pooled baseline-data. A cluster analysis was performed on the 15 QLQ-C30 HRQoL-scales in the overall dataset, as well as by cancer type and selected patient characteristics to examine the robustness of the results. The dataset consisted of 20,066 patients pooled across 17 cancer types. Overall, three main clusters were identified (R This study successfully validated prior findings by Martinelli (2011): the QLQ-C30 scales are interrelated and can be grouped into three main clusters. Knowing how these multidimensional HRQoL scales are related to each other can help clinicians and patients with cancer in managing symptom burden, guide policymakers in defining social-support plans and inform selection of HRQoL scales in future clinical trials.
Identifiants
pubmed: 35569438
pii: S0959-8049(22)00187-3
doi: 10.1016/j.ejca.2022.03.039
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.